ArticleCell reports. Medicine2023

Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.

Brittiny Dhital et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.